University of Minnesota
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Minnesota sits in the top decile of US sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count).
University of Minnesota: 966 sponsored US clinical trials, 180 recruiting.
University of Minnesota sponsors 966 registered US clinical trials on ClinicalTrials.gov, 180 of them currently recruiting, and 671 completed. 71 of these trials are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 14 trials.
Top-decile sponsor footprint
University of Minnesota ranks in the top decile of sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
671 of 731 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
966 total, page 14 of 20
Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung Specimens
NCT02128711
S. Aureus Screening and Decolonization
NCT02182115
Yoga in the Treatment of Eating Disorders: a Randomized Trial
NCT02191995
Dismantling the Components and Dosing of CBT for Co-Occurring Disorders
NCT02161211
Comparing Web, Group, and Telehealth Formats of a Military Parenting Program
NCT02973906
Progesterone & Postpartum Relapse to Smoking
NCT01798394
Treatment of Masked Hypertension
NCT02142881
Genetics of Hyperuricemia Therapy in Hmong
NCT02371421
Single Dose Intranasal Oxytocin and Cognitive Effects in Autism
NCT02493426
Carvedilol PAH A Pilot Study of Efficacy and Safety
NCT02120339
ACTH in Progressive Forms of MS
NCT01950234
Smoking, Stress & Allopregnanolone Response
NCT02087800
Longitudinal Outcomes in Pediatric rTMS and CIT
NCT02091687
Overgeneralization of Conditioned Fear as a Pathogenic Marker of Anorexia Nervosa
NCT02148042
BDNF and Motor Learning
NCT02074696
Quantitative Methods for Supplementing Contrast-Enhanced Magnetic Resonance Imaging of Breast Cancer
NCT02058758
Brain-Computer Interface and Mind-Body Awareness Training
NCT02074722
A Brain Centered Neuroengineering Approach for Motor Recovery After Stroke: Combined rTMS and BCI Training
NCT02132520
Development of an Instrument That Monitors Behaviors Associated With OCD
NCT02866422
Non-Invasive Brain-Computer Interface for Virtual Object Control
NCT02071485
Defeating Urinary Incontinence With Exercise Training (DUET) Feasibility Study
NCT02206958
Exergaming Intervention in ALL Patients
NCT02118324
Effects of Aerobic Exercise for Treating Alzheimer's Disease
NCT01954550
Brain Computer Interface Control of a Robotic Device
NCT02069938
Community Walking Exercise for Patients With Peripheral Artery Disease
NCT02075502
Satiety Effects of the Combination of Egg and Whole Grains
NCT02272153
Comparing the Location of the Motor Cortex in Children Using Two Methods
NCT02015338
Closed Loop Insulin Pump Therapy After Islet Auto-Transplantation
NCT01945138
Measurement of Arch Motion After Bunion Surgery
NCT02074748
Dental Office Prevention Strategies for Children
NCT02004990
Dose Escalation Study of Intravenous Baclofen in Healthy Adult Volunteers
NCT01931319
Photobiomodulation Therapy Using the Realief Therapy System for the Treatment of Chemotherapy-associated Peripheral Neuropathy
NCT02000908
Integrative Cognitive-Affective Therapy for Binge Eating Disorder
NCT02043496
Bartonella in Liver Transplant Patients
NCT02595710
Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors
NCT02000921
Markers of Pubertal Suppression During Therapy for Precocious Puberty
NCT02006680
Morning Versus Evening Dosing of Antihypertensive Medications: A Pilot Study to Assess Feasibility and Efficacy
NCT01965847
Evaluation of a "Flash-free" Adhesive Resin for Orthodontic Bracket Bonding
NCT02030002
Prospective Evaluation of Anorganic Bovine Bone Mineral Versus Calcium Phosphosilicate Alloplastic Bone Putty in Direct Sinus Augmentation: a Spilt-mouth Study
NCT01942304
Medicinal Nicotine for Preventing Cue Induced Craving
NCT02347605
Evaluation of Cessation Preferences of Menthol Smoker
NCT02020005
Repetitive Transcranial Magnetic Stimulation Use in Acute Stroke
NCT01922986
Post-Gastric Bypass Hypoglycemia
NCT01933490
Effects of Sertraline on Brain Connectivity in Adolescents With OCD
NCT02797808
Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease
NCT02112825
Methods Project 4: Clinical Trial
NCT01867242
Characterizing and Predicting Drug Effects on Cognition
NCT01889602
Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT
NCT01835249
Topiramate in Adolescents With Severe Obesity
NCT01859013
Adaptive Intervention Strategies in Conduct Problems Prevention
NCT02414074
What is open in the University of Minnesota pipeline
180 recruiting of 966 indexed (19% open); 671 completed (69%).
Phase mix: 71 late (III/IV) vs 206 early (I/II) (early-phase heavy).
Top condition: Obesity (14 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Minnesota: open-pipeline peers nationwide
Peers matched on 966 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 966 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Alabama at Birmingham · 19% recruiting · 1,160 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Minnesota page
966 registered trials is a research-attention snapshot, not an endorsement of University of Minnesota or any single study.
- 180 of University of Minnesota's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Minnesota studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Minnesota pipeline card: 966 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.